{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:58:04Z","timestamp":1785455884727,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR 5\/13\/93\/2020\/NCD-III"],"award-info":[{"award-number":["ICMR 5\/13\/93\/2020\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2018\/002638"],"award-info":[{"award-number":["ECR\/2018\/002638"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SPG\/2021\/004209"],"award-info":[{"award-number":["SPG\/2021\/004209"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/2018\/AIIMS- B\/1153"],"award-info":[{"award-number":["DBT\/2018\/AIIMS- B\/1153"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cyto.2023.156155","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T09:53:11Z","timestamp":1682070791000},"page":"156155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt\/Erk-NF\u03baB axis in oral cancer"],"prefix":"10.1016","volume":"166","author":[{"given":"Swarali","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156155_b0005","first-page":"845","article-title":"Prevalence of oral cancer in India","volume":"7","author":"Varshitha","year":"2015","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.cyto.2023.156155_b0010","first-page":"108","article-title":"Trends of head and neck cancers in Urban and rural India","volume":"7","author":"Elango","year":"2006","journal-title":"Asian Pacific J. Cancer Prev."},{"key":"10.1016\/j.cyto.2023.156155_b0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0022034511402082","article-title":"Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions","volume":"23","author":"Johnson","year":"2011","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.cyto.2023.156155_b0020","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.5272\/jimab.2016224.1385","article-title":"Survival Rates in Oral Cancer Patients \u2013 a 10-Year Retrospective Study","volume":"22","author":"Tonchev","year":"2016","journal-title":"J. IMAB \u2013 Annu. Proceeding (Scientific Pap."},{"key":"10.1016\/j.cyto.2023.156155_b0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2023.156155_b0025","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.cyto.2023.156155_b0035","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1902\/jop.2013.130320","article-title":"Salivary Interleukin-6 and -8 in Patients With Oral Cancer and Patients With Chronic Oral Inflammatory Diseases","volume":"85","author":"Lisa Cheng","year":"2014","journal-title":"J. Periodontol."},{"key":"10.1016\/j.cyto.2023.156155_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107692","article-title":"Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression","volume":"219","author":"Fousek","year":"2021","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.cyto.2023.156155_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-015-0703-y","article-title":"The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116","volume":"32","author":"Dabkeviciene","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0045","doi-asserted-by":"crossref","first-page":"42031","DOI":"10.18632\/oncotarget.9662","article-title":"IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib","volume":"7","author":"Fernando","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2023.156155_b0050","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/0008-5472.CAN-19-3791","article-title":"Chemotherapy-induced IL8 upregulates MDR1\/ABCB1 in tumor blood vessels and results in unfavorable outcome","volume":"80","author":"Kikuchi","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0055","first-page":"69","article-title":"Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer growth and metastasis","volume":"375","author":"Wu","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cyto.2023.156155_b0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12094-014-1240-4","article-title":"Interleukin-8 promotes human ovarian cancer cell migration by epithelial\u2013mesenchymal transition induction in vitro","volume":"17","author":"Yin","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0065","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3892\/ijo.2016.3371","article-title":"Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil","volume":"48","author":"Wang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.oraloncology.2013.03.452","article-title":"Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma","volume":"49","author":"Gyanchandani","year":"2013","journal-title":"Oral Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0075","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.oraloncology.2007.12.002","article-title":"Roles of CXCL8 in squamous cell carcinoma proliferation and migration","volume":"44","author":"Christofakis","year":"2008","journal-title":"Oral Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0080","doi-asserted-by":"crossref","first-page":"56375","DOI":"10.18632\/oncotarget.16914","article-title":"IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK\/ERK-NF-\u03baB pathway and reduction of JNK in HNSCC","volume":"8","author":"Chan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2023.156155_b0085","doi-asserted-by":"crossref","first-page":"61820","DOI":"10.18632\/oncotarget.11445","article-title":"IL-8 promotes HNSCC progression on CXCR1\/2-meidated NOD1\/ RIP2 signaling pathway","volume":"7","author":"Chan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2023.156155_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cyto.2023.156155_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep23932","article-title":"MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features","volume":"6","author":"Ghosh","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2023.156155_b0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41419-020-2627-5","article-title":"The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cyto.2023.156155_b0155","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/jir.2019.0070","article-title":"Evaluation of Serum and Salivary Interleukin-6 and Interleukin-8 Levels in Oral Squamous Cell Carcinoma Patients: Systematic Review and Meta-Analysis","volume":"39","author":"Rezaei","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2023.156155_b0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1368-8375(02)00006-4","article-title":"Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines","volume":"38","author":"Watanabe","year":"2002","journal-title":"Oral Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0110","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/acs.molpharmaceut.1c00213","article-title":"MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer","volume":"18","author":"Sayyed","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cyto.2023.156155_b0115","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/jcmm.14848","article-title":"IL-8 promotes cell migration through regulating EMT by activating the Wnt\/\u03b2-catenin pathway in ovarian cancer","volume":"24","author":"Wen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cyto.2023.156155_b0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1158\/1541-7786.MCR-19-0595","article-title":"IL8 expression is associated with prostate cancer aggressiveness and androgen receptor loss in primary and metastatic prostate cancer","volume":"18","author":"Maynard","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0125","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-11-0156","article-title":"IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells","volume":"71","author":"Fernando","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cyto.2016.07.013","article-title":"Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs","volume":"86","author":"Ha","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2023.156155_b0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.oraloncology.2006.09.001","article-title":"The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines","volume":"43","author":"White","year":"2007","journal-title":"Oral Oncol"},{"issue":"11","key":"10.1016\/j.cyto.2023.156155_b0145","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/j.oraloncology.2009.06.001","article-title":"CAL 27 is an oral adenosquamous carcinoma cell line","volume":"45","author":"Jiang","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.cyto.2023.156155_b0150","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.3892\/mmr.2017.7747","article-title":"IL-8 promotes proliferation and inhibition of apoptosis via STAT3\/AKT\/NF-\u03baB pathway in prostate cancer","volume":"16","author":"Guo","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cyto.2023.156155_b0100","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0170","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1073\/pnas.0806677106","article-title":"Stimulated nuclear translocation of NF-kappaB and shuttling differentially depend on dynein and the dynactin complex","volume":"106","author":"Shrum","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2023.156155_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3436","article-title":"Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells","volume":"15","author":"Singh","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI39397","article-title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts","volume":"120","author":"Ginestier","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2023.156155_b0175","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00280-018-3584-x","article-title":"IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1)","volume":"81","author":"Du","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cyto.2023.156155_b0180","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-07-1162","article-title":"Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer","volume":"67","author":"Araki","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0190","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/1078-0432.CCR-13-3203","article-title":"Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins","volume":"20","author":"Sanmamed","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2023.156155_b0195","first-page":"4771","article-title":"Downregulation of foxp3 in neutrophils by il-8 promotes the progression of oral squamous cell carcinoma","volume":"18","author":"Zeng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cyto.2023.156155_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/life11050423","article-title":"Interleukin-6 and interleukin-8 regulate stat3 activation migration\/invasion and emt in chrysophanol-treated oral cancer cell lines","volume":"11","author":"Hsu","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.cyto.2023.156155_b9030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cyto.2023.156155_b0205","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ijc.25562","article-title":"Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models","volume":"128","author":"Ning","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2023.156155_b0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2015.3234","article-title":"IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)","volume":"48","author":"Long","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cyto.2023.156155_b0215","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.cyto.2023.156155_b9035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.cyto.2023.156155_b9040","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2021.642238","article-title":"Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential","volume":"2","author":"Niklander","year":"2021","journal-title":"Front. Oral. Health"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:40:15Z","timestamp":1778794815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":46,"alternative-id":["S1043466623000339"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156155","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt\/Erk-NF\u03baB axis in oral cancer","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156155"}}